Buy Generic Cyproterone Acetate And Ethinylestradiol Online

Generic Cyproterone Acetate And Ethinylestradiol Information

Introduction

Cyproterone Acetate and Ethinylestradiol is a combined hormonal preparation classified as a hormone medication. It is widely prescribed in Hong Kong for the treatment of androgen‑dependent skin disorders and as a combined oral contraceptive. The product contains the anti‑androgen cyproterone acetate and the estrogen ethinylestradiol, both of which are synthetic hormones that have been evaluated by international regulatory agencies such as the European Medicines Agency (EMA) and the U.S. Food and Drug and Cosmetic Act.

What is Cyproterone Acetate and Ethinylestradiol?

• Definition – A tablet that delivers a fixed dose of cyproterone acetate (an androgen receptor antagonist) together with ethinylestradiol (a potent synthetic estrogen).
• Classification – Combined hormonal therapy; falls under the broader group “Hormones.”
• Development & Manufacturer – Originally developed by Schering‑Plough (now part of Bayer) for the brand‑name product Diane‑35. Many generic manufacturers produce the same formulation under the International Non‑Proprietary Name (INN).

Cyproterone Acetate and Ethinylestradiol is the generic version of Diane‑35, containing the same active compound Cyproterone Acetate and Ethinylestradiol. Our online pharmacy provides this generic alternative as a cost‑effective treatment option.

How Cyproterone Acetate and Ethinylestradiol Works

1. Cyproterone acetate binds competitively to androgen receptors in skin, hair follicles and the hypothalamic‑pituitary‑gonadal axis, reducing the biological effects of testosterone and of more potent dihydrotestosterone (DHT). This anti‑androgenic action decreases sebum production and slows the growth of terminal hair.
2. Ethinylestradiol suppresses the hypothalamic release of gonadotropin‑releasing hormone (GnRH), leading to lower luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) secretion. The resulting decrease in ovarian androgen synthesis complements the anti‑androgenic effect of cyproterone acetate.
3. The combined effect produces ovarian suppression, providing reliable contraception, while simultaneously mitigating androgen‑driven conditions such as severe acne and hirsutism.
4. Pharmacokinetics: Both compounds reach peak plasma concentrations within 1–3 hours after oral ingestion. Cyproterone acetate has a half‑life of ≈ 30 hours, allowing once‑daily dosing; ethinylestradiol has a half‑life of ≈ 24 hours. Clearance occurs primarily via hepatic metabolism (CYP3A4).

Conditions Treated with Cyproterone Acetate and Ethinylestradiol

• Severe facial acne that is resistant to topical therapy or oral antibiotics.
• Hirsutism (excessive male‑pattern hair growth) in women with hyperandrogenism.
• Polycystic ovary syndrome (PCOS)‑related hyperandrogenic symptoms when contraception is also required.
• Contraception for women seeking a combined oral contraceptive (COC) with added anti‑androgenic benefit.

Relevance to Hong Kong: Dermatology clinics in Hong Kong report a prevalence of moderate to severe acne in up to 12 % of young adults, and hirsutism affects an estimated 3–5 % of women of reproductive age. Access to an anti‑androgenic COC provides a dual therapeutic advantage, reducing the need for multiple separate medications.

Patient Groups Most Likely to Benefit

• Women of reproductive age with clinical signs of androgen excess (e.g., acne, hirsutism) who also desire reliable contraception.
• Patients with PCOS who need menstrual regulation and reduction of androgenic symptoms.
• Individuals who have failed first‑line acne treatments (topical retinoids, benzoyl peroxide, oral tetracyclines).

 Contraindications / Not appropriate –

• Pregnant or breastfeeding women.
• Women with a history of venous thromboembolism, stroke, myocardial infarction, or estrogen‑sensitive malignancies.
• Severe hepatic impairment, uncontrolled hypertension, or known hypersensitivity to either component.

Risks, Side Effects, and Interactions

Common

• Nausea, abdominal discomfort, and mild headache.
• Breast tenderness or enlargement.
• Changes in menstrual bleeding pattern (spotting, breakthrough bleeding).
• Mild weight gain or fluid retention.

Rare

• Elevated liver enzymes; hepatic dysfunction reported in < 1 % of users.
• Hyperprolactinemia causing galactorrhea.
• Mood changes, including depressive symptoms.

Serious

• Venous thromboembolism (VTE) – deep‑vein thrombosis or pulmonary embolism.
• Arterial thrombotic events – myocardial infarction, ischemic stroke.
• Severe hepatic injury – cholestatic hepatitis, hepatic necrosis.

Drug‑Drug Interactions

• CYP3A4 inducers (e.g., rifampicin, carbamazepine, St. John’s wort) may lower plasma levels, reducing efficacy.
• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, grapefruit juice) can increase cyproterone acetate concentrations, potentially heightening side‑effect risk.
• Anticoagulants (warfarin) – ethinylestradiol may enhance anticoagulant effect; close INR monitoring is required.
• Lithium – increased risk of lithium toxicity; serum lithium levels should be checked periodically.

Practical Use: Dosing, Missed Dose, Overdose

• Standard dosing – One tablet daily for 21 consecutive days, followed by a 7‑day hormone‑free interval (or continuous low‑dose regimen as directed by a clinician). Typical dose: 2 mg cyproterone acetate + 35 µg ethinylestradiol per tablet.
• Missed dose – If a dose is missed by less than 12 hours, take it as soon as remembered, then continue with the next scheduled dose. If more than 12 hours have passed, skip the missed tablet, resume the regular schedule, and use a non‑VTE barrier method (e.g., condom) for the next 7 days.
• Overdose – Symptoms may include nausea, vomiting, dizziness, and breast tenderness. Seek immediate medical attention; activated charcoal is ineffective, but supportive care and monitoring are recommended.
• Precautions –
  • Take the tablet with water, preferably at the same time each day.
  • Alcohol does not directly affect efficacy but can worsen liver enzyme elevations.
  • Patients with a history of migraine with aura should avoid combined estrogen–progestin products.

Buying Cyproterone Acetate and Ethinylestradiol from Our Online Pharmacy

Cyproterone Acetate and Ethinylestradiol can be purchased securely from our online pharmacy in Hong Kong.

• Affordable pricing – We source the generic formulation directly from licensed overseas manufacturers, offering prices close to the manufacturer’s cost.
• Verified quality – Every batch is inspected for authenticity, potency, and packaging integrity by accredited third‑party laboratories.
• Guaranteed delivery – Discreet, reliable shipping options are available, including express delivery within 7 days for Hong Kong residents and regular airmail (≈ 3 weeks) for other Asian territories.
• Online‑only access – Our pharmacy broker service collaborates with internationally licensed pharmacies, enabling patients who face limited local stock or insurance restrictions to obtain the medication safely.
• Privacy‑focused – Orders are packaged without branding, and all personal data are handled in compliance with Hong Kong’s Personal Data (Privacy) Ordinance.

FAQ

• Is Cyproterone Acetate and Ethinylestradiol available in both brand‑name and generic forms in Hong Kong?
  Yes, the medication is marketed under the well‑known brand name Diane‑35 and is also available as a generic formulation. Generic versions contain the identical active ingredients and are typically offered at a lower cost.

• Does Cyproterone Acetate and Ethinylestradiol require cold storage?
  No special temperature control is needed. Store the tablets at room temperature, away from moisture, direct sunlight, and excessive heat.

• What packaging does Cyproterone Acetate and Ethinylestradiol come in when ordered online?
  The medication is supplied in sealed blister packs containing 21 tablets per pack, with each pack labeled in English and Traditional Chinese for clarity.

• Can Cyproterone Acetate and Ethinylestradiol be safely imported into Hong Kong for personal use?
  Personal import is allowed provided the product is accompanied by a valid prescription and complies with Hong Kong Customs regulations on medication quantities (typically up to a three‑month supply).

• Are there manufacturer warnings specific to Asian populations?
  The EMA and FDA labeling note that Asian women may have a slightly higher baseline risk of VTE when using combined oral contraceptives; clinicians should assess individual risk factors before prescribing.

• Do formulation details differ between regions such as the EU, US, and Asia?
  The core active ingredients are identical, but excipient composition (e.g., filler or coating agents) may vary to meet local pharmacopeial standards. These differences do not affect therapeutic efficacy.

• Can Cyproterone Acetate and Ethinylestradiol be incorporated into telemedicine treatment plans?
  Yes, many telehealth providers in Hong Kong integrate this medication into remote management of acne or PCOS, provided a licensed practitioner conducts a thorough medical history and assessment.

• and How does the professional evaluation step work for online orders?
  Every order placed with our service undergoes a mandatory review by an independent, licensed healthcare professional. The reviewer examines the health information supplied at checkout to confirm that the medication is appropriate and safe for the individual. If additional details are required, our care team contacts the customer to obtain clarification before a prescription is issued.

• What is the typical time frame from order placement to delivery in Hong Kong?
  Express shipping delivers within 7 business days to most Hong Kong addresses, while standard airmail may take up to 3 weeks, depending on customs processing.

• Are there any age restrictions for purchasing Cyproterone Acetate and Ethinylestradiol online?
  The medication is indicated for adult women (≥ 18 years). Our online pharmacy verifies age and prescription eligibility before processing any order.

• Will my pharmacist provide counseling on how to start the medication?
  Yes, after prescription approval, a licensed pharmacist will supply written counseling information, covering dosing schedule, missed‑dose instructions, potential side effects, and when to seek medical attention.

Glossary

Androgen receptor antagonist

A substance that blocks the binding of male hormones (androgens) to their cellular receptors, reducing androgen‑driven effects such as excess oil production and hair growth.

Combined oral contraceptive (COC)

A birth‑control pill that contains both an estrogen and a progestin (or anti‑androgen) to suppress ovulation and prevent pregnancy.

Venous thromboembolism (VTE)

The formation of blood clots in the venous system, which can manifest as deep‑vein thrombosis or travel to the lungs as a pulmonary embolism; a recognized risk of estrogen‑containing contraceptives.

⚠️ Disclaimer

The information provided about Cyproterone Acetate and Ethinylestradiol is for general knowledge only. It does not replace professional medical consultation. All treatment decisions should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Cyproterone Acetate and Ethinylestradiol for individuals who may have limited availability through traditional pharmacies, prescription‑based insurance schemes, or who are seeking affordable generic alternatives. Always consult a doctor before starting, changing, or discontinuing any medication.